Jeffrey Rhodes has served on the Board of Directors since May 2020. Mr. Rhodes is a Partner of TPG, where he co-leads the healthcare group and the firm’s investment activities in the healthcare services, pharmaceutical, and medical device sectors. Mr. Rhodes also serves on the boards of Beaver-Visitec International, Immucor, Kelsey Seybold Clinic, Kindred at Home, Kindred Healthcare, and WellSky. Mr. Rhodes previously served on the Boards of Biomet, EnvisionRx, IMS Health, Par Pharmaceutical Companies, Surgical Care Affiliates, Zimmer Biomet, and as a founding Board member of the Healthcare Private Equity Association. Mr. Rhodes holds a Bachelor of Arts degree in economics from Williams College and an MBA from Harvard Business School.